Accelerating precision ophthalmology: recent advances

Introduction: The future of ophthalmology is precision medicine. With a growing incidence of lifestyle-associated ophthalmic disease such as diabetic retinopathy, the use of technology has the potential to overcome the burden on clinical specialists. Advances in precision medicine will help improve diagnosis and better triage those with higher clinical need to the appropriate experts, as well as providing a more tailored approach to treatment that could help transform patient management. Areas covered: A detailed literature review was conducted using OVID Medline and PubMed databases to explore advances in precision medicine within the areas of retinal disease, glaucoma, cornea, cataracts and uveitis. Over the last three years [2019–2022] are explored, particularly discussing technological and genomic advances in screening, diagnosis, and management within these fields. Expert opinion: Artificial intelligence and its subspecialty deep learning provide the most substantial ways in which diagnosis and management of ocular diseases can be further developed within the advancing field of precision medicine. Future challenges include optimal training sets for algorithms and further developing pharmacogenetics in more specialized areas

Enhancing Retinal Scan Classification: A Comparative Study of Transfer Learning and Ensemble Techniques

Ophthalmic diseases are a significant health concern globally, causing visual impairment and blindness in millions of people, particularly in dispersed populations. Among these diseases, retinal fundus diseases are a leading cause of irreversible vision loss, and early diagnosis and treatment can prevent this outcome. Retinal fundus scans have become an indispensable tool for doctors to diagnose multiple ocular diseases simultaneously. In this paper, the results of a variety of deep learning models (DenseNet-201, ResNet125V2, XceptionNet, EfficientNet-B7, MobileNetV2, and EfficientNetV2M) and ensemble learning approaches are presented, which can accurately detect 20 common fundus diseases by analyzing retinal fundus scan images. The proposed model is able to achieve a remarkable accuracy of 96.98% for risk classification and 76.92% for multi-disease detection, demonstrating its potential for use in clinical settings. By utilizing the proposed model, doctors can provide swift and accurate diagnoses to patients, improving their chances of receiving timely treatment and preserving their vision

Deployment of Artificial Intelligence in Real-World Practice: Opportunity and Challenge.

Artificial intelligence has rapidly evolved from the experimental phase to the implementation phase in many image-driven clinical disciplines, including ophthalmology. A combination of the increasing availability of large datasets and computing power with revolutionary progress in deep learning has created unprecedented opportunities for major breakthrough improvements in the performance and accuracy of automated diagnoses that primarily focus on image recognition and feature detection. Such an automated disease classification would significantly improve the accessibility, efficiency, and cost-effectiveness of eye care systems where it is less dependent on human input, potentially enabling diagnosis to be cheaper, quicker, and more consistent. Although this technology will have a profound impact on clinical flow and practice patterns sooner or later, translating such a technology into clinical practice is challenging and requires similar levels of accountability and effectiveness as any new medication or medical device due to the potential problems of bias, and ethical, medical, and legal issues that might arise. The objective of this review is to summarize the opportunities and challenges of this transition and to facilitate the integration of artificial intelligence (AI) into routine clinical practice based on our best understanding and experience in this area

A Review on Machine Learning Methods in Diabetic Retinopathy Detection

Ocular disorders have a broad spectrum. Some of them, such as Diabetic Retinopathy, are more common in low-income or low-resource countries. Diabetic Retinopathy is a cause related to vision loss and ocular impairment in the world. By identifying the symptoms in the early stages, it is possible to prevent the progress of the disease and also reach blindness. Considering the prevalence of different branches of Artificial Intelligence in many fields, including medicine, and the significant progress achieved in the use of big data to investigate ocular impairments, the potential of Artificial Intelligence algorithms to process and analyze Fundus images was used to identify symptoms associated with Diabetic Retinopathy. Under the studies, the proposed models for transformers provide better interpretability for doctors and scientists. Artificial Intelligence algorithms are also helpful in anticipating future health issues after appraising premature cases of the ailment. Especially in ophthalmology, a trustworthy diagnosis of visual outcomes helps physicians in advising disease and clinical decision-making while reducing health management costs